Oerlikon Investor Presentation slide image

Oerlikon Investor Presentation

Group impacted by COVID-19 pandemic in 2Q20; OMF performed well with strong bookings in CHF million 2Q20 2Q19 y-o-y HY20 HY19 y-o-y Order intake 604 672 -10.1% 1'081 1'352 -20.1% Sales (3rd parties) 510 700 -27.2% 1'039 1'324 -21.5% Operational 55 123 -55.3% 114 218 -47.7% EBITDA In % of sales 10.8% 17.6% 10.9% 16.4% Operational EBIT 4 73 -94.0% 11 118 -90.5% In % of sales 0.9% 10.4% 1.1% 8.9% Top-line development at constant FX (y-o-y) 672 -4.2% 644 -22.6% 700 542 cerlikon ▪ 2Q20 Group Orders declined by 10.1% vs. 2Q19 due to significant COVID-19 impact on Surface Solutions - Manmade Fibers order intake increased by 22.8% Group Sales declined by 27.2% vs. 2Q19 Lower activity in Surface Solutions in all business lines due to COVID-19 Manmade Fibers sales declined by 22.8% vs. 2Q19 related to high sales in previous year – full year delivery schedules to be largely unaffected and on track - Negative FX impact on Sales and Orders from continuing strengthening of reporting currency CHF Operational EBITDA at 10.8% – strong cost control measures only partially offset lower cost absorption due to the significant decline in sales Restructuring impairment charges to enable cost out actions of CHF 26m excluded from operational results Order intake 2Q 2019 Order intake 2Q 2020 at constant FX Sales 2Q 2019 Page 42 Oerlikon Investor Presentation October 2020 Sales 2Q 2020 at constant FX
View entire presentation